Study of Demographic, Clinical and Therapeutic Characteristics of Patients with Autoimmune Hepatitis in Al-Zahra Hospital

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Assistant Professor, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

10.48305/jims.v43.i822.0778

Abstract

Background: Autoimmune hepatitis (AIH) is a chronic liver disease that responds well to treatment if diagnosed and treated promptly, but can lead to cirrhosis and liver failure if left untreated. This study aimed to determine the demographic, clinical and therapeutic characteristics of patients with autoimmune hepatitis in Al-Zahra Hospital.
Methods: This descriptive study was conducted on 111 adult patients with a definitive diagnosis of AIH based on diagnostic scoring criteria and code (ICD-10: K75.4) at Al-Zahra Hospital from 2006 to 2018. Patients diagnosed with viral hepatitis, metabolic diseases, or other liver diseases were excluded from the study. Demographic, clinical, laboratory, imaging, and pathological data were collected and reported with descriptive statistics.
Findings: Of the 111 patients studied, 59.5% were female and 40.5% were male with a mean age of 42.5 years. The most common clinical manifestations included fatigue (55%), jaundice (75%), and pruritus (43%). 46.3% of biopsied patients had bridging necrosis. 15% of patients had cirrhosis at the time of diagnosis. The response to treatment in the first year was 71%, and the 1-year survival rate was reported to be 95%. The mortality rate over the 3-year follow-up period was 3%, which is lower than that reported in similar global studies.
Conclusion: The estimated prevalence of AIH in Isfahan was approximately 6 per 100,000 people. The course of the disease and response to treatment in this population were more favorable than in Western countries, which may be attributed to early diagnosis and appropriate treatment. However, prospective studies are recommended to more accurately investigate the factors affecting prognosis and response to treatment.

Highlights

Babak Tamizifar: Google Scholar, PubMed 

Vahid Sebghatollahi: Google Scholar

Keywords

Main Subjects

References

  1. Shahramian I, Mohammadi MH, Kalvandi GR. A review of autoimmune hepatitis and diabetes [in Persian]. J Diabetes Nurs 2019; 6(4): 664-71.
  2. Kalantari H, Ebadi S, Yaran M, Maracy MR, Shahshahan Z. Prevalence and risk factors of hepatitis B and C viruses among hemodialysis patients in Isfahan, Iran. Adv Biomed Res 2014; 3: 73.
  3. Nejad SEM, Heiat M, Javanbakht M, Alavian SM, Haris MAA. Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center. BMC Gastroenterol 2024; 24(1): 17.
  4. Goya M RR, Faleh H, Sohrabpour A. Guide to the treatment of chronic hepatitis B in Iran for general practitioners [in Persian]. Tehran: Ministry of Health, Treatment and Medical Education, Deputy Health and Iranian Hepatitis Network; 2010.
  5. Daryani NE, Mirmomen S, Bahrami H, Mohammadi HR. Epidemiological indices of 39 subjects with autoimmune hepatitis and their response to treatment in Iran [in Persian]. GOVARESH. 2016; 5(29&30): 135-40.
  6. Ebrahimi Dariani N TM, Shirzad S, Tabataba Vakili S. Liver enzyme disorders [in Persian]. Scientific Journal of the Medical System Organization of the Islamic Republic of Iran 2012; 30(3): 272-87.
  7. Tanaka A, Ma X, Yokosuka O, Weltman M, You H, Amarapurkar DN, et al. Autoimmune liver diseases in the Asia-Pacific region: Proceedings of APASL symposium on AIH and PBC 2016. Hepatol Int 2016; 10(6): 909-15.
  8. Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut 2021; 70(10): 1989-2003.
  9. Haider AS, Kaye G, Thomson A. Autoimmune hepatitis in a demographically isolated area of Australia. Intern Med J 2010; 40(4): 281-5.
  10. Grønbæk L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol 2014; 60(3): 612-7.
  11. Kim TI, Kagihara JE, Tsai NC, Roytman MM. Autoimmune Hepatitis in Hawai'i. Hawaii J Med Public Health 2015; 74(8): 270-4.
  12. Choudhuri G, Somani SK, Baba CS, Alexander G. Autoimmune hepatitis in India: profile of an uncommon disease. BMC Gastroenterol 2005; 5: 27.
Journal of Isfahan Medical School
Volume 43, Issue 822
2nd Week,, September
July and August 2025
Pages 778-783

Files

History

  • Receive Date: 17 June 2025
  • Accept Date: 30 August 2025

Share

How to cite

Statistics